How has Vaxcyte, Inc.'s capital investments accrued but not yet paid changed year-over-year?

Vaxcyte, Inc.'s capital investments accrued but not yet paid increased by 63.1% year-over-year, from $3.89M to $6.34M.

Vaxcyte, Inc. PCVX Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

EAT

Brinker InternationalEAT

$300K-98.7%

Schneider NationalSNDR

$37.7M+109%

ACM ResearchACMR

$13.18M-43.7%

US FoodsUSFD

$64M+56.1%

PlexusPLXS

$2.55M-65.7%

PayPal Holdings, Inc.PYPL

$2.25M-35.7%

Other financials

Income statement

See full

Operating income-$345.9M-91.3%

Net income-$320.6M-128%

EPS (diluted)-$2.30-121%

Balance sheet

See full

Cash & equivalents$262.3M-24.7%

Total debt$116.3M+33.5%

Total equity$3.0B-6.4%

Total assets$3.3B-0.9%

Cash flow

See full

Operating cash flow-$280.6M-68.8%

CapEx$2.1M-61.2%

Free cash flow-$282.7M-64.7%

Valuation

See full

Market cap$7.43B+72.0%

Enterprise value$7.28B+78.6%

Returns & leverage

See full

Return on equity-30.6%+37.9pp

Debt / equity0×0.0×

Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vaxcyte, Inc.'s capital investments accrued but not yet paid?: Vaxcyte, Inc. (PCVX) reported capital investments accrued but not yet paid of $6.34M in Q1 2026.
How has Vaxcyte, Inc.'s capital investments accrued but not yet paid changed year-over-year?: Vaxcyte, Inc.'s capital investments accrued but not yet paid increased by 63.1% year-over-year, from $3.89M to $6.34M.